Low risks to volunteers from phase I clinical drug trials, study shows Fears over the risk of serious harms to volunteers in non-oncology phase I trials are unjustified, according to the results of a meta-analysis published in The BMJ.…
Hospital e-referral initiative boosts post-discharge MURs in community pharmacies Project highlighted in RPS guide refers patients for medicines reviews to reduce readmission risk.…
Pregnancy: use of medicines in managing complications How physiological changes during pregnancy are managed to minimise risk to the mother and foetus.…
Researchers suggest indefinite anticoagulation for patients with unprovoked pulmonary embolism Research into the benefits of warfarin for patients who have suffered a blockage in a lung artery suggest that the anticoagulant should be administered indefinitely.…
European Medicines Agency launches safety review of HPV vaccines A safety review of human papillomavirus vaccines, which protect young women against cervical cancer, has been launched by the European Medicines Agency.…
Giving pharmacists access to summary care records will improve patient care Pharmacists must seize the opportunity offered by read-only access to summary care records and prove that full access to GP patient notes is the logical next step.…
Australia moves to allow biosimilar substitution The independent body that advises the Australian government about which drugs it should subsidise has taken steps towards allowing pharmacists and clinicians to substitute a biosimilar product for a biologic therapy.…
Inappropriate prescribing putting asthma patients’ lives at risk, warns charity Thousands of patients with asthma in the UK are not being prescribed the right medication to keep their condition under control, finds an audit of GP practice records by the charity body Asthma UK.…
England’s top doctor orders review into how medicines are evaluated The chief medical officer for England has ordered an independent review into the efficacy and safety of medicines to address a growing perception that doctors and scientists are “untrustworthy”.…
Study highlights contribution made by critical care pharmacists Specialist critical care pharmacists can make a “substantial” contribution to achieving the best use of medicines for patients cared for in hospital critical care units, finds new research.…